A U.S. regulator grants full approval to the Pfizer vaccine, the first to get such a clearance. But not everyone agrees with the decision. What are the concerns?
Business growth slowed in July as supply chain problems persisted and demand cooled off. NTD talks to an American manufacturer.
Read More